Login / Signup
Cailing Xiang
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 3
Top Topics
Transcription Factor
Ejection Fraction
Peritoneal Dialysis
Free Survival
Top Venues
ImmunoTargets and therapy
BioMed research international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kaiwu Xu
,
Cailing Xiang
,
Zhige Yu
,
Jia Li
,
Changjun Liu
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis.
ImmunoTargets and therapy
13 (2024)
Kaiwu Xu
,
Cailing Xiang
,
Zhige Yu
,
Jia Li
,
Changjun Liu
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis.
ImmunoTargets and therapy
13 (2024)
Tailiang Lu
,
Chenglong Li
,
Cailing Xiang
,
Yongqiang Gong
,
Wei Peng
,
Chaowu Chen
Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
BioMed research international
2022 (2022)